SIA
MRNA icon

Strategic Investment Advisors’s Moderna MRNA Stock Holding History

Strategic Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,587
Closed -$1.45M – 249
2023
Q4 		$1.45M Buy
14,587
+8,208
+129% +$690K 0.21% 70
2023
Q3 		$659K Buy
6,379
+2,126
+50% +$237K 0.11% 145
2023
Q2 		$517K Sell
4,253
-6,419
-60% -$856K 0.07% 137
2023
Q1 		$1.64M Buy
10,672
+6,234
+140% +$1.03M 0.3% 55
2022
Q4 		$797K Sell
4,438
-14
-0.3% -$2.29K 0.17% 102
2022
Q3 		$527K Sell
4,452
-35
-0.8% -$5.31K 0.12% 134
2022
Q2 		$641K Buy
4,487
+192
+4% +$27.4K 0.13% 129
2022
Q1 		$740K Buy
+4,295
New +$723K 0.14% 131

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Strategic Investment Advisors's MRNA Position: Q1 2024 in Review

Strategic Investment Advisors sold out of Moderna (MRNA) in Q1 2024, closing a stake of 14,587 shares — an estimated $1.45M sold.

Strategic Investment Advisors first reported a position in MRNA in Q1 2022 and held it in 8 quarters. The position peaked at $1.64M in Q1 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Strategic Investment Advisors reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Strategic Investment Advisors sold 14,587 Moderna shares in Q1 2024, an estimated $1.45M.
  • Strategic Investment Advisors first reported a position in Moderna in Q1 2022 and held it in 8 quarters.
  • Strategic Investment Advisors's Moderna position peaked at $1.64M in Q1 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Strategic Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.